StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.19−0.02 (-10.00%)

Close on Nov 18, 2026Market cap $852.76KP/E –Yield –

Oragenics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Oragenics's gross profit for the twelve months ending Dec 31, 2016 was $0. For fiscal 2017 it was $0. The highest annual figure on record is $730.82K in fiscal 2011.

Annual gross profit

PeriodPeriod endValueChange
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0-100.0%
FY2014Dec 31, 2014$570.33K-17.2%
FY2013Dec 31, 2013$688.88K+52.0%
FY2012Dec 31, 2012$453.30K-38.0%
FY2011Dec 31, 2011$730.82K+84.0%
FY2010Dec 31, 2010$397.12K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Oragenics figures

See a number that looks wrong?